Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Australian Healthcare Herald.
Press releases published on April 2, 2025
Top Landmarks Around The World to Spark The Night Blue for Parkinson's Awareness
EIN Presswire
·
April 2, 2025
500+ Top Landmarks Around the World to Spark Blue for Parkinson’s Awareness on April 11 VANCOUVER, BC, CANADA, April 2, 2025 /EINPresswire.com/ -- In an inspiring show of solidarity, some of the world’s most iconic landmarks are set to illuminate in …
COAF Launches Appeal to Build Sports Complex for Children in Rural Armenia
EIN Presswire
·
April 2, 2025
The Children of Armenia Fund (COAF) will raise $200,000 to provide over 1,600 children weekly with a modern space for sports and play. YEREVAN, YEREVAN, ARMENIA, April 2, 2025 /EINPresswire.com/ -- The Children of Armenia Fund (COAF) has officially …
Join us for The Son-Rise Program® In-Person Start-Up
EIN Presswire
·
April 2, 2025
Autism Treatment Center of America® announces The Son-Rise Program® In-Person Start-Up in Sheffield, Massachusetts, June 23rd - 27th. SHEFFIELD, MA, UNITED STATES, April 2, 2025 /EINPresswire.com/ -- The Son-Rise Program, a transformative approach to …
Mesoblast Files Request for Type B Meeting with FDA to Discuss Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure
GlobeNewswire
·
April 2, 2025
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on its plans to meet with the United States Food and Drug Administration (FDA) …
A' Accessibility, Assistive Technologies, and Inclusive Design Award Announces Final Call for Entries
EIN Presswire
·
April 2, 2025
The prestigious A' Accessibility, Assistive Technologies, and Inclusive Design Award extends final submission opportunity until April 7, 2025 COMO, CO, ITALY, April 2, 2025 /EINPresswire.com/ -- The A' Accessibility, Assistive Technologies, and …
ENA Respiratory Announces Publication Supporting the Potential of its Novel Intranasal Therapy INNA-051 to Reduce the Impact of Viral Respiratory Infections in Older Adults
GlobeNewswire
·
April 2, 2025
Clinical studies demonstrated that INNA-051’s natural defence boosting mechanism is effective in older adults Administration of INNA-051 to older adults (65 years old) in a Phase 1 study was well-tolerated and increased important antiviral host-defence …